Sagent Pharmaceuticals – Recall of ketorolac tromethamine injection
May 1, 2019 - The FDA announced a voluntary user-level recall of one lot of Sagent Pharmaceuticals’ ketorolac tromethamine injection due to microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products.
Top